Clinical Trial Update: Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy

View source ↗

Summary

This clinical trial is recruiting to study factors that influence the effectiveness of post-transplant cyclophosphamide in leukemia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Leukemia, Not Otherwise Specified, Leukemia, Other | Status: RECRUITING